Clinical Trials
3 trialsNCT02566993 2021-10-28
ATLANTIS
PharmaMar
Phase 3 Completed
NCT00483509 2019-10-04
NGR007
AGC Biologics S.p.A.
Phase 2 Completed
NCT00003847 2013-09-05
VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer
Vertex Pharmaceuticals Incorporated
Phase 2 Terminated